SCHEMBL14422698

SCHEMBL14422698

Clc1ccc(-c2nnc3ccc(N4CCCCC4)nn23)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.76
HSD17B10 Q99714 7/20 0.73
HTT P42858 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
HPGD P15428 6/20 0.58
MAPT P10636 5/20 0.58
ALDH1A1 P00352 5/20 0.58
KDM4E B2RXH2 5/20 0.58
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
TSHR P16473 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
TP53 P04637 2/20 0.57
TDP1 Q9NUW8 1/20 0.57
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
CDC7 O00311 1/20 0.56
MAP4K4 O95819 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4783215 0.87 PIM1 (0.78) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL4739564 0.86 PIM1 (0.77) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL11750772 0.86 PIM1 (0.75) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL11539600 0.84 HSD17B10 (0.74) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL4782912 0.79 HPGD (0.55) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL32665352 0.77 MAPT (0.57) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL5619103 0.76 PIM1 (0.67) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL4781880 0.76 PIM1 (0.67) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL5618450 0.76 PIM1 (0.55) PIM1HSD17B10HTTSMN1; SMN2HPGD
SCHEMBL4784537 0.76 HPGD (0.48) PIM1HSD17B10HTTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268136-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-09-11 US disclosed
US-7268136-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-09-11 US disclosed